Articles related to PEER-TO-PEER

Explore the intricate relationship between neurocognitive and psychiatric disorders with insights from Dr. Lokesh Shahani. Learn about the importance of early diagnosis, differentiation, and the latest therapeutic options for effective patient care.

Explore the insights of a family physician who tested ChatGPT’s understanding of a typical day in medical practice. Discover where the AI excels and where it falls short, particularly in areas like billing and time management.

Dr. Marc Agronin discusses the evolving landscape of telepsychiatry, emphasizing its potential and challenges, especially for the elderly.

The updated ASCO guidelines for stage IV NSCLC provide new treatment recommendations based on the latest evidence. Explore these changes and their potential impact on patient care.

Explore the potential implications of the formation of Risant Health on community oncology, as discussed by industry experts in a recent episode of Cancer Care Business Breakthroughs. Learn about the potential challenges and opportunities this new entity could bring to the healthcare landscape.

The KEYNOTE-789 study results have sparked a debate on the role of immunotherapy in treating stage IV EGFR-mutated NSCLC. While the study did not show a significant benefit of adding pembrolizumab to chemotherapy, experts agree that the potential role of immunotherapy, particularly in combination with anti-angiogenic therapy, should not be completely dismissed.